P218-3869 Screening compound: 1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-4-[2-(4-ethoxyphenyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carbonyl]piperidine

P218-3869 Screening compound: 1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-4-[2-(4-ethoxyphenyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carbonyl]piperidine
P218-3869 Screening compound: 1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-4-[2-(4-ethoxyphenyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carbonyl]piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound P218-3869
1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-4-[2-(4-ethoxyphenyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carbonyl]piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P218-3869

Molecular Formula

C26H33N5O5S (C26 H33 N5 O5 S)

Compound Name

1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-4-[2-(4-ethoxyphenyl)-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-5-carbonyl]piperidine

IUPAC name

1-[(35-dimethyl-12-oxazol-4-yl)sulfonyl]-4-[2-(4-ethoxyphenyl)-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-5-carbonyl]piperidine

SMILES

CCOc(cc1)ccc1-c1nn(CCCN(C2)C(C(CC3)CCN3S(c3c(C)onc3C)(=O)=O)=O)c2c1

InChI

InChI=1S/C26H33N5O5S/c1-4-35-23-8-6-20(7-9-23)24-16-22-17-29(12-5-13-31(22)27-24)26(32)21-10-14-30(15-11-21)37(33,34)25-18(2)28-36-19(25)3/h6-9,16,21H,4-5,10-15,17H2,1-3H3

InChI Key

IVRGDSBDJGTZKA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31958460

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

527.64

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.583

Distribution Coefficient, logD

2.583

Water Solubility, LogSw

-2.95

Polar Surface Area

91.290

Acid Dissociation Constant (pKa)

23.05

Base Dissociation Constant (pKb)

-0.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

P218-3869 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with P218-3869 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P218-3869?
Check Price and Availability of P218-3869, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P218-3869 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P218-3869
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P218-3869
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P218-3869 available by request